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Abstract 
A new hydrazone ligand (2-(Methoxycarbonyl-hydrazono)-pentanedioic acid, H2L), derived from 
methyl carbazate and α-ketoglutaric acid, and its Ag(I) complex [Ag(HL)(H2L)] were 
synthesised and characterised by elemental, spectral and thermal analyses. The X-ray 
structures of the ligand and complex were determined. The silver ion is hexa-coordinated to 
two tridentate (O, N, O) hydrazone ligands in a distorted octahedral environment. The 
binding carboxylic acid group is protonated in one of the ligands (netural) while it is present 
as the carboxylate in the other (negatively charged) ligand. The bulk material of the complex 
thermally decomposes to form metallic silver sheets. The ability to scavenge radical of both, 
the ligand and complex, was studied against these radicals: DPPH•, ABTS•+, NO• and O2.-. 
The binding affinity and mode of binding towards CT-DNA were recorded by UV-absorption 
and the ethidium bromide displacement method. The interaction of ligand and complex with 
bovine serum albumin was investigated using UV-Vis, fluorescence and synchronous 
spectroscopic methods. The silver complex showed strong binding propensity than the free 
Schiff base ligand in binding studies. The antimicrobial activity was studied against both 
bacteria and fungi strains and the silver complex exhibited significant activity as compared to 
the ligand alone. Significantly high antimicrobial activity was noticed especially for 
Staphylococcus aureus, and Escherichia coli which were extensively studied by MIC 
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methods. Furthermore, the ligand and complex show potential cytotoxicity towards the MCF-
7 breast cancer cell line. Both of them have been found to induce apoptosis confirmed by 
AO/EtBr and DAPI staining assays. 
Key words  
Hydrazones; apoptosis staining; antimicrobial activity; DNA- and BSA- binding. 
1. Introduction 
Metal complexes containing methyl and ethyl carbazates (R-O-CO-NH-NH2, R= -CH3, -
C2H5) have been of considerable interest due to their interesting thermal and structural 
properties [1-9]. Carbazates are interesting as ligands in view of their variety of potential 
oxygen and nitrogen donar atoms and these neutral molecules are expected to exhibit only 
one a common coordination mode, namely bidendate N, O- chelation. Apart from its 
coordination ability, alkyl carbazates can also undergo condensation reactions; the hydrazinic 
part of the terminal amine group reacts with the carbonyl groups of aldehydes or ketones to 
form Schiff bases. However, Schiff bases and their metal complexes derived from methyl and 
ethyl carbazate have not been studied except our own recent reports [10-13] of Schiff bases 
derived from analogous benzyl carbazate with alkyl and heteroaryl ketones and their metal 
complexes. 
The ability of Schiff base complexes to interact with DNA and proteins has attracted much 
attention in the search for new chemotherapeutic agents and nucleic acid structural probes 
[14,15]. Also our recent study [11] has shown that the Schiff base complexes strongly bind to 
HSA, the essential distributors of metal ions, drugs and various metabolites throughout the 
human body [16]. Therefore, to obtain new pharmaceutically active compound is to combine 
different pharmacophore groups in the same molecule. In this context, α- Ketoglutaric acid is 
a naturally occurring ketoacid and an important intermediate in the Krebs cycle, which 
generates energy for life processes. Further, from the literature survey, it appears that the 
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work involving Schiff base complexes derived from α- Ketoglutaric acid and hydrazine 
derivatives was the reports on thiosemicarbazide [17] and substituted thiosemicarbazide [18]. 
Against this background we have examined the synthesis and characterisation of silver(I) 
complex of Schiff base ligand derived from methyl carbazate and α- Ketoglutaric acid, and 
studied their chemical and biological behaviour. Metal-based drugs exhibit more cytotoxic 
activity against cancer cells than their corresponding ligands. The present study describes the 
antimicrobial and cytotoxic activity of this silver (I) complex. The antioxidant activity and 
binding studies towards DNA, BSA have also been carried out and discussed herein. 
2. Experimental  
2.1. Material and methods 
All reagents and chemicals used were of Analytical reagent grade (A.R) and of highest 
purity. Doubly distilled water was used as a solvent in all preparations and experiments. Calf 
thymus CT-DNA, Tris–Tris(hydroxymethyl)methylamine, Ethidium bromide (EB),  were 
purchased from sigma. The stock solution of CT-DNA was prepared in 5 mM Tris HCl/50 
mM NaCl at pH 7.2 and the ratio of absorbance at 260 & 280 nm above 1.8:1 indicating that 
the CT-DNA preparation was free from protein contaminations [19]. BSA stock was prepared 
by dissolving the BSA in 50 mM phosphate buffer at pH 7.4. All stock solutions were stored 
at 4˚C and used within two days. The Human breast cancer and normal breast epithelial cells 
were purchased from the National Centre for Cell Sciences (NCCS), Pune, India.  
Elemental analysis for C, H, and N were performed on a Vario-ELIII elemental analyser. 
The IR spectra were recorded on a JASCO- 4100 spectrophotometer as KBr pellets in the 
range of 4000-400 cm-1. Simultaneous TG-DTA studies were done on a Perkin – Elmer Pyris 
Diamond thermal analyser and the curves obtained in air using platinum cups as holders with 
3 mg of the samples at the heating rate of 10˚C/min. Absorption spectral analysis were 
performed using JASCO V-630 UV-Visible spectrophotometer with quartz cuvettes of path 
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length 1cm. NMR spectra were recorded on a Breuker Avance III spectrometer operating at 
400MHz for 1H and 100 MHz for 13C. 1H/13C NMR chemical shifts are reported in ppm and 
tetramethyl silane (TMS) used as an internal reference.  
Crystal data were collected using a Xcalibur, Sapphire3 diffractometer (MITIGEN holder 
in perfluoroether oil) equipped with an Oxford Cryosystems 700 Plus Series low-temperature 
apparatus operating at T = 120(2)K. Data were measured ω scans of 1.0° per frame for 6.0 s 
using MoKα radiation (Enhanced (Mo) X-ray Source, 50 kV, 35 mA).  The total number of 
runs and images was based on the strategy calculation from the program CrysAlisPro 
(Agilent) [20]. Actually achieved resolution was Θ = 26.498(Ag) 32.844(L). Data reduction 
was performed using the CrysAlisPro (Agilent) software which corrects for Lorentz 
polarisation. The absorption coefficient (µ) of the ligand and complex are 0.139 & 1.134 and 
the minimum and maximum transmissions are 0.904 and 0.981 & 0.738 and 0.886 
respectively. Using Olex2 the structure was solved with the olex2.solve structure solution 
program, in the Charge Flipping solution method [21,22]. The model was refined with 
version of SHELXL using Least Squares minimisation [23]. All non-hydrogen atoms were 
refined anisotropically. Hydrogen atom positions were calculated geometrically and refined 
using the riding model. 
2.2. Synthesis  
H2L: Alpha ketoglutaric acid (0.146 g, 1 mmol) and methyl carbazate (0.092 g, 1 mmol) 
were dissolved in 20 mL of doubly distilled water and heated on a water bath for 4 h. The 
resulting clear solution was allowed to crystallize at room temperature. Block shaped 
colourless crystals formed after three days, were filtered off, washed with cold water 
followed by ethanol and air dried.  Yield: 95%, Elemental analysis found: C, 35.68%; H, 
5.20%; N, 11.58%. C7H12N2O7: Calc.  C , 35.59%; H, 5.12%; N, 11.86%. UV-Vis (10-3 M, 
λmax, nm (ε [M-1cm-1])): 240 (20450), 289 (17500). FT-IR (KBr, cm-1): 3607, 3476 (OH), 
3214 (NH), 1739 (C=O), 1602 (C=N), 1048 (N-N). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 
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10.73(s, NH), 3.73(s, OCH3), 3.71(s, H2O), 2.69-2.65(t, 7.4 Hz, CH2), 2.38-2.34 (t, 7.6 Hz, 
CH2). 13C NMR (100 MHz, DMSO-d6): 173.48 (C7), 165.38 (C1), 154.09 (C3), 143.52 (C2), 
52.41 (C4), 29.66 (C6), 21.06(C5). 
[Ag(HL)(H2L)]: To a hot  aqueous solution (20 mL) of ligand (0.472 g, 2 mmol), 0.170 g of 
silver nitrate (1 mmol) dissolved in 20 mL of water was added in drops with continuous 
stirring, over water bath to prevent precipitation. Careful addition of aqueous solution of 3-4 
drops of triethylamine was made to facilitate complexation. The resulting solution on 
evaporation at ambient condition resulted polycrystalline solid which was separated as 
before. The compound was stored in dark at all times. Glossy white crystals suitable for 
diffraction studies were obtained only at fifth time of crystallisation. Yield: 88%. Elemental 
analysis found: C, 30.70%; H, 3.01%; N, 10.41%. Ag, 19.70%; C14H19AgN4O12: Calc.  C , 
30.95%; H, 3.52%; N, 10.31%; Ag, 19.85%. UV-Vis (10-3 M, λmax, nm (ε [M-1cm-1])): 242 
(24800), 293 (18600). FT-IR (KBr, cm-1): 3420 (OH), 3209 (NH), 1724 (C=O), 1585 (C=N) 
1545, 1266 (COO-), 1056 (N-N). 1H NMR (400 MHz, DMSO-d6, δ, ppm): 8.30(s, NH), 3.74 
(s, OCH3), 3.65 (s, OCH3), 2.74-2.70 (t, 7.8 Hz, CH2), 2.60-2.57(t, 7.4 Hz, CH2), 2.47-2.42 (t, 
7.4 Hz, CH2), 2.39-2.35 (t, 7.6Hz, CH2). 13C NMR (100 MHz, DMSO-d6):173.87 (C7), 
165.31 (C1), 79.10 (C3 & C2), 52.45 (C4), 29.74 (C6), 21.26 (C5). 
2.3. DNA binding studies  
Ligand and complex were first dissolved in DMSO to give 1 mM stock solutions, 
which further diluted in 5 mM Tris HCl/50 mM NaCl buffer at pH 7.2. Electronic absorption 
spectra were recorded in the range of 200-500 nm by increasing concentration of CT-DNA 
(30 µM) to the complex (50 µM). The solution mixture was kept for 10 min at equilibrium 
before recording spectrum. Competitive EB binding study was performed in order to 
investigate that compounds could replace EB from EB-DNA system by fluorescence 
spectroscopic titration. The fluorescence emission spectra were recorded in the wavelength 
range of 530-700 nm, with excitation wavelength at 525 nm after successive addition of 
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compounds to a solution containing 8 µM EB and 10 µM CT-DNA. 
2.4. Albumin binding studies 
Binding studies with protein by tryptophan fluorescence quenching experiments were 
performed using Bovine Serum Albumin (BSA) as a model protein. Like DNA binding 
studies, compound’s stock solutions were prepared by using 50 mM phosphate buffer instead 
of Tris HCl buffer. A 3 mL solution containing appropriate concentration of BSA (5 µM) was 
titrated by successive additions of 5 µL stock solution of compounds (0-40 µM). 
Simultaneously, synchronous fluorescence spectra of the mixture were recorded in the range 
of 270-400 nm by setting ∆λ =15 nm and ∆λ =60 nm (difference between the excitation and 
emission wavelengths of BSA) for tyrosine and tryptophan residues respectively. UV 
absorption spectra of BSA were recorded in phosphate buffer in the absence and presence of 
increasing concentration of compounds. 
2.5. Antioxidant assays 
In vitro radical scavenging assays were performed in triplicate and standard deviation of 
absorbance was less than 10% of the mean. Ascorbic acid (AA) and butylated hydroxyl 
anisole (BHA) are used as positive control in all assays. 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) free radical scavenging activity was measured using the method described by Shih-
Chuan Liu et al [24]. Total antioxidant activity assay was studied using ABTS radical cation 
decolourisation assay [25]. The effect of super oxide radical scavenging activity was 
determined by the nitroblue tetrazolium reduction method and described by Wei Fu et al [26]. 
Nitric oxide (NO) scavenging activity was performed based on the Griess assay [27]. For the 
above four assays, all of the tests were run in triplicate and the percentage of activity was 
calculated using the formula: 
%	of	scavenging	capacity =  	× 100                                         (1) 
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A0 and Ac are the absorbance in the absence and presence of the tested compounds,   
respectively. The 50 % activity (IC50) can be calculated using the percentage of activity. 
2.6. Antimicrobial assay 
The antibacterial activity of the prepared ligand and its silver complex were tested in 
vitro against three gram-positive bacteria Bacillus subtilis, Staphylococcus aureus, and 
Stapylococcus albush and three gram-negative bacteria Salmonella paratyphi, Escherichia 
coli and Klebsella pneumonia using agar-well diffusion method [28, 29]. Antifungal activities 
of the compounds were screened against C.albicans, A.fumigates and A.niger using disc 
diffusion method. Also, the minimum concentrations of the synthesised compounds to inhibit 
the microorganisms (MIC) were determined by the micro broth dilutions technique strictly 
following the National Committee for Clinical Laboratory Standards (NCCLS) 
recommendations [30, 31]. In all determinations, tests were performed in duplicate and the 
results were reported as mean of these values. 
2.7. Evaluation of cytotoxicity  
The inhibitory concentration (IC50) value was evaluated using an MTT [3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. The optical density was 
measured at 620 nm in an ELISA multiwell plate reader (Thermo Multiskan EX, USA). The 
OD value was used to calculate the percentage of viability using the following formula. 
%	of	viability = 		 !	"#	!$%!&'(!)*	+(%!	 !	"#	!$%!&'(!)*	,")*&"	× 100                         (2) 
2.7.1. Morphological study & Fluorescence microscopic analysis 
The MCF-7cells that were grown on cover slips (1×105 cells/cover slip) incubated for 
6-24 h with compounds at the IC50 concentration and the mono layers per experimental group 
were photo micrographed. Approximately 1µL of a dye mixture (100 mg/mL acridine orange 
(AO) and 100 mg/mL ethidium bromide (EtBr) in distilled water) was mixed with 9 mL of 
cell suspension (1×105 cells/mL) on clean microscope cover slips. The selected cancer cells 
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were collected, washed and stained with 1 mL of AO/EtBr. After incubation for 2 min, the 
cells were visualized with an excitation filter at 480 nm. Likewise the cells were placed on 
glass coverslip in a 24-well plate and treated with complex for 24 h. The fixed cells were 
permeabilised with 0.2% triton X-100 (50 µL) for 10 min at room temperature and incubated 
for 3 min with 10 µL of DAPI by placing a coverslip over the cells to enable uniform 
spreading of the stain.  
3. Results and discussion 
The ligand (H2L) was prepared by the condensation reaction of α-keto glutaric acid with 
methyl carbazate (Scheme 1). Silver complex was isolated by stoichiometric (1:2) reaction of 
silver nitrate with the ligand. Repeated crystallisation of the mother liquor yielded crystalline 
silver complex. Both the ligand and complex were soluble in water, alcohol and DMSO. 
They were characterised by elemental analysis, FT-IR, UV-Vis, NMR (1H & 13C) and TG-
DTA measurements. Further, the formation of both the ligand and complex were 
characterised by single crystal X- ray diffraction. 
3.1. Spectroscopic Characterisation 
The IR spectra provide valuable information regarding the nature of functional groups 
present in both ligand and complex (Fig. S1). Solid state FT-IR spectrum of the ligand shows 
sharp doublet at 3607, 3476 cm–1 assigned to O-H vibrations of lattice water and carboxylic 
group respectively. The ν(C=N) stretching vibration is found at a lower frequency for silver 
complex (1585 cm-1) than the ligand (1602 cm–1) indicating the involvement of azomethine 
nitrogen towards metal coordination. The asymmetric and symmetric stretching frequencies 
of the coordinated carboxylate group are seen in 1545, 1360 cm−1, respectively with a 
separation ∆ν (νasym − νsym) of 185 cm−1 indicating monodentate coordination of carboxylate 
ion [32]. The electronic spectra of the ligand and complex were recorded in aqueous medium. 
The broad band observed at 240 and 290 nm could be assigned to n–pi* and pi–pi* transitions 
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respectively within the organic ligand. Minor shift with increase in intensity was observed for 
the complex, which may be attributed to the chelation of ligand.  
The 1H and 13C NMR spectra (Fig. S2-S5)  have been recorded for the ligand and 
complex in DMSO-d6 solution and the peak assignments are compared with the literature 
values [17, 33]. In 1H NMR spectrum of the ligand, appearance of an important signal at  
10.73 ppm has been assigned to NH proton; in complex this signal is shifted to  8.30 ppm. A 
peak at 3.73 ppm is due to –OCH3 proton, where as in complex two signals appearing at 3.74 
and 3.65 ppm indicate that the two methoxy protons are magnetically nonequivalent and are 
in different chemical environment around metal. A peak at 3.71 ppm with an integration 
corresponds to two protons is assigned for a water molecule in the ligand. The methylene 
protons of ligand nearer to carboxylic and  azomethine groups are observed in the region 
between 2.69-2.65 and 2.38-2.34 ppm respectively [33]. In complex, methylene protons are 
observed as four triplets in the range of 2.73-2.35 ppm corresponding to two independent 
(neutral and anionic) ligands. 
In the 13C NMR spectra of ligand and complex, the carboxylic carbon (-COOH) 
signals appear in the most downfield region at 173 and 165 ppm for C7 & C1 carbons 
respectively. For the ligand, signals of carbonyl (C3) and azomethine (C2) carbons are 
noticed  at 154 and 143 ppm respectively. In the complex, these signals exhibited largest 
upfield shift to 79 ppm due to the closest proximity of these atoms to the central metal ion 
[34]. In both the ligand and complex, the methoxy (C4) carbons gave signal at 52 ppm and 
methylene carbons appear at 29 and 21 ppm for C6 & C5 respectively. 
3.2. Stability in aqueous media 
Rapid (AgCl) precipitation in biological media results severe problem in treatment of 
silver based drugs with wounds. Effective treatment of infections requires sustained release 
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of silver ions to the infections which were focused by researchers [35]. In this context, water 
soluble silver complex was subjected by stability measurements in water at 37 ºC. As shown 
in Fig. S6, silver complex slowly releases Ag+ ions and confirm its silver donating ability to 
the targets. Periodic assessment of absorption spectrum over a period of 90 min reveals that 
the transitions in spectrum slowly transfers to the spectrum of free ligand [36], after that there 
is no change in absorption spectrum. 
3.3. Thermal analysis 
In order to further characterize these compounds in terms of thermal stability, their 
thermal behaviour was investigated by simultaneous TG-DTA under air that is shown in Fig. 
S7. A summary of thermal data of the compounds are presented in Table S1 with the 
decomposition of intermediates and final products best fitted with the corresponding mass 
loss in TG curve. Simultaneous TG-DTA of the ligand shows an endothermic decomposition 
at 150 ˚C to give ethanimine as an intermediate with the mass loss of 82.50% (Calcd. 
81.36%). This kind of carbazate Schiff bases are known to decompose via ethanimine 
intermediate [12]. Then the intermediate decomposes exothermically with almost 100% mass 
loss to give gaseous products.  
The network of silver complex was stable up to 200 ˚C, above that the framework start to 
collapse. An abrupt mass loss at 218 ˚C accompanied by the endothermic decomposition of 
organic components leads to the formation of silver propionate as a probable intermediate 
(Obsd. 67.00%, Calcd. 66.73%). The decomposition ended at 600 ˚C in which, the DTA 
curve shows a strong exothermic peak (500 ˚C) due to the loss of the carboxylate ligand and 
formation of metallic silver as the final decomposition product (Obsd. 19.5%, Calcd. 19.9%). 
It has been observed that thermal degradation of silver complex led to the formation of 
metallic silver [37]. Powder X-ray diffraction studies were performed to determine the 
crystalline nature and phase purities of complex and the silver. Fig S8 shows the X-ray 
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diffractograms of complex and silver. The PXRD patterns exhibit number of peaks that are 
sharp and intense indicating their pure and highly crystalline nature. Four distinct diffraction 
peaks are observed at 2θ values of 38.2◦, 44.3◦, 64.5◦ and 77.4◦, corresponding to the (111), 
(200), (220) and (311) reflections of cubic Ag (JCPDS No. 4-0783). The surface 
morphological feature of metallic silver was studied by FESEM. Detailed FESEM 
micrographs are presented in Fig. S9 with magnification of 15,000 was shown to be sheet 
like pattern. EDX elemental analysis indicates that the sheet composed of pure silver. The 
observation of larger nano particles may be attributed to the fact that they have a tendency to 
agglomerate due to the high surface energy of ultrafine nanoparticles.  
3.4. Crystal Structure 
X-ray crystallography reveals that both the ligand and complex crystallize in 
monoclinic crystal system with the space group of P21/c (Figs. 1a & 1b). Crystal data and 
details of structure refinement are given in Table 1. Selected bond lengths and bond angles 
are listed in Table S2. Hydrogen bonding parameters are given in Tables S3 & S4. 
The ligand possesses condensed unit of ketoglutaric acid and methyl carbazate with a 
lattice water molecule as asymmetric unit with Z=4. The schiff base formation was verified 
by comparing the bond distances. The C2-N1 bond distance is 1.28(4) Å that is appreciably 
close to that of C=N double bond, confirming the formation of Schiff base ligand [38].  The 
bond distance of C3-O3 is 1.218(4) Å which is very close to C=O bond length (1.21 Å). 
Schiff base ligands are linked through oxygen atom of water molecule (O1W) and forming 
hydrogen bonds (strong O-H...O, N-H...O and weak C-H...O interactions) to generate 1D 
chain parellel to a axis (Fig S10). In addition to that one of the carbonyl oxygens (O1) of 
carboxyl group forms bifurcated acceptor from O-H and C-H group of adjacent ligand. 
Surprisingly, the solvated water molecule acts as a linker between the chains and generate 
R22(8) ring motif. And also noticed that the carbonyl group of carbazate moiety acts as 
bifurcated acceptor from the lattice water molecles. 
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In [Ag(H2L)(HL)],  silver atom is hexa-coordinated with distorted octahedral 
environment being bonded to two tridentate hydrazone ligands. In the complex, both the 
neutral and uni-negative ligands are coordinated to the metal in a tridentate N,O,O chelate 
fashion. The two carboxylate entities of the ligand in the complex are not equivalent; O2A is 
protonated, while O2B is not, and resulting overall complex as neutral. This assessment is 
entirely supported by the fact that much shorter Ag to O1B (charged) distance of 2.475Å 
compared to 2.505Å for the protonated carboxylic acid (Fig. S11). Two Schiff base ligands 
found to be coordinated via azomethine nitrogen, carbonyl oxygen of methyl carbazate and 
carboxylic oxygen of acid resulting four five membered chelate rings around the metal with  
bite angles of 66.09, 66.80, 66.16 and 67.00˚. The angle between the plans passing through 
the ligands is 83.66˚, indicating that the neutral and negatively charged ligands are nearly 
perpendicular to each other. The crystal packing of complex is largely achieved through O-
H...O, N-H...O and C-H...O hydrogen bonds. The oxygen (O5) atom from uncoordinated acid 
group plays a bifurcated acceptor from the O6 of adjacent ligand generating 1D wave like 
chain. Two adjacent antiparallel chains are connected by C-H...O5 hydrogen bonding from 
the methyl group of carbazate. In addition to that, interestingly, O2A atom acts as bifurcated 
donor to the oxygen atoms (O1B, O2B) of coordinated carboxylic group of adjacent chain 
creating 2D network (Fig. S12). As a whole, anhydrous neutral silver complex creates 
extended structure by means of various hydrogen bonds to generate 3D supramolecular 
network. 
3.5. DNA binding studies 
Biochemical evaluation of silver(I) complexes is related mostly to their action, which 
appears to involve interaction with DNA. Moreover, DNA is the major target of many 
anticancer drugs. Electronic absorption spectra were carried out to examine the bonding 
mode and ability with CT-DNA [39]. The interaction of ligand and complex with CT-DNA 
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was followed by recording the UV- Visible spectra in fixed concentrations (Fig S13). Upon 
addition of CT-DNA, an increase in absorption intensity in the range of 210-300 nm, a 
hyperchromism of ligand centred transition was observed. These observations indicate that 
there are non- classical external intercalation between CT-DNA and compounds which might 
be electrostatic and/or groove binding modes or the compounds could uncoil the helical 
structure of DNA. These indicate that the compounds possess strong affinity towards DNA. 
Furthermore, the binding mode is proved through displacement studies 
3.5.1. Competitive studies with ethidium bromide 
Ethidium bromide (EB-3,8- diamino-5-ethyl-6-phenyl-phenanthridium bromide) is a 
standard intercalator forming stable complex with CT-DNA and emits intense fluorescence 
due to the interaction of planar phenanthridium ring between adjacent base pair in the double 
helix. The emission of spectra of EB-DNA system in the absence and presence of ligand and 
complex are shown in Fig S14. Reduction in fluorescence intensity of DNA-EB system by 
about 18.41 and 33.86 % observed for ligand and silver complex respectively. These results 
indicate that the compound would effectively compete with EB for binding sites on DNA [40, 
41]. The relative quenching efficiency of the compounds to CT-DNA was determined by the 
classical Stern-Volmer equation [42, 43] 
-
- = 1 + /01[3]                               (3) 
Here Fo and F are the fluorescence intensities in the absence and the presence of the 
quencher, respectively. KSV is the Stern–Volmer dynamic quenching constant and [Q] is the 
total concentration of the quencher. The linear fit plot of F0/F versus [complex]/ [DNA], KSV 
is given by the ratio of the slope to intercept. The KSV value of ligand and complex were 
calculated as 2.47×105 and 4.75×105 M-1 respectively.  The slightly higher binding constant 
of complex implies that it relatively has better interaction with DNA as compared to ligand. 
  
14 
 
3.6. Albumin binding studies 
Bovine serum albumin (BSA) is the most abundant transport protein in blood plasma 
and the interaction between antitumor drugs and BSA may have effect on their bioavailability 
and toxicity [44-46]. It is of great interest to use quenching of the intrinsic tryptophan 
fluorescence of BSA (Trp-212 and Trp-134) as a tool to study the interaction of BSA with the 
synthesised compounds [47, 48]. Fluorescence titration studies have been performed using 5 
µM BSA and varying the concentration of compounds (0−40 µM) in the range 290−500 nm. 
The effect of compounds upon addition on the fluorescence emission spectra of BSA is 
shown in Fig S15. The fluorescence intensity of BSA at ∼348 nm quenched with no shift up 
to 28.8% and 35.7% of the initial intensity of BSA for the ligand and Ag (I) complex, 
respectively. The type of quenching progression was explored by the absorption spectra of 
BSA. Dynamic quenching affects only the excited state of fluorophore (not changing the 
absorption spectrum), whereas static quenching leads to perturbation of fluorophore. The 
emission intensity of BSA increases as the addition of compounds with small blue shift, 
revealing the existence of static quenching [49]. 
To investigate the structural changes that occurred in BSA upon the addition of 
compounds, synchronous fluorescence spectra of BSA were measured [50]. According to 
Miller, in synchronous fluorescence spectroscopy the difference between the excitation and 
emission wavelengths (∆λ = λem − λex) reflects the spectra of a different nature of 
chromophores [51]. If the ∆λ value is 15 nm, the synchronous fluorescence of BSA is 
characteristic for tyrosine residue, whereas ∆λ value of 60 nm is characteristic for tryptophan 
residue [52]. The effect of compounds on synchronous fluorescence spectra of BSA are 
shown in Figs. S16 & S17 of ESI. It is apparent that the intensity of Trp or Tyr residues 
decreases in the presence of ligand and complex. Tyr emission intensity was found to 
decrease up to 14.5 and 25% whereas Trp fluorescence emission showed significant decrease 
  
15 
 
of about 23.3 and 30.6% for ligand and silver complex respectively. However, the emission 
peak position of Trp or Tyr residues does not show significant shift, indicating that the 
polarity around Trp or Tyr residues is unchangeable [53]. So, the presence of compounds 
does not obviously affect the ??-helical conformation of BSA.  
3.6.1. Binding Parameters 
Florescence quenching data were analysed to obtain various binding parameters and 
quenching progression for the interaction of compounds and BSA. The quenching data were 
analysed with Stern-Volmer and Scatchard equation [54]. The quenching constant (Kq) was 
calculated using the plot of ??0/?? versus [??] giving a straight line, and Kq is thus obtained 
from the slope of the diagram (Fig 2). The values of Kq obtained are 4.1 × 105   & 5.4 × 106   
M-1 at 298 K for ligand and complex respectively. Static quenching binding constant (K) and 
number of binding sites can be determined using the following Scatchard eqn (4) 
789 :-;-- < = 789/ + =789[3]                                             (4) 
Where K is the binding constant of quencher, determined from the slope of log [(F0 − F)/F] 
versus log [Q] as shown in inset plot Fig. S15. The calculated value of binding constant (K) 
for ligand and its complex with BSA was found to be 9.05× 105 and 1.15 × 106 M-1 and the 
number of binding sites (n) was 0.73 and 0.87 respectively. Little higher magnitude of Kq & 
K for Ag complex compared to that of free ligand indicated a higher affinity of metal towards 
protein environment. 
3.7. Antioxidant assays 
To investigate the antioxidant activity of both the ligand and its silver complex in 
vitro, ABTS•+, DPPH•, NO•, O2•- scavenging assays were carried out based on the decay of 
free radical UV-Vis absorbance quenched by antioxidants [55]. The IC50 values for 
compounds and standard (natural Ascorbic acid (AA) and synthetic Butylated hydroxyl 
anisole (BHA)) antioxidants against free radicals are displayed in Fig. 3. 
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Free radicals are known to be a major factor in biological damages, and DPPH• has 
been used to evaluate the free radical scavenging activity of natural antioxidants [56, 57].  
The antioxidant present in sample reacts with DPPH radical and converts into reduced form 
either by donating hydrogen atom or transferring electron followed by proton [58]. From the 
results, both the ligand and complex with an IC50 value of 9.31 and 12.48 mg/mL respectively 
indicate that they have the ability to scavenge free radicals and could serve as a strong free 
radical inhibitor or scavenger according to standard. ABTS assay is an excellent tool for 
determining the antioxidant activity of hydrogen‐donating antioxidants and of chain‐breaking 
antioxidants [59]. The compounds efficiently scavenged ABTS radicals generated by the 
reaction between ABTS and potassium persulfate. The ligand exhibited an IC50 value of 
16.58 mg/mL somewhat comparable with silver complex (34.49 mg/mL). Superoxide radical, 
known to be very harmful to cellular components as a precursor of the more reactive oxygen 
species, contributes to tissue damage and various diseases [60]. The superoxide anion radicals 
O2.– scavenging activity was determined by nitro blue tetrazolium (NBT) method.  
Scavengers present in the sample compete with NBT for radicals and slowdown the 
formation of blue colour, which is quantitatively measured at 560nm [61]. [Ag(HL)(H2L)] 
shows an excellent superoxide radical scavenging activity comparable to both standards with 
the IC50 value of 9.46 mg/mL. Sodium nitroprusside in aqueous solution at physiological pH 
spontaneously generates nitric oxide, interacts with oxygen to produce nitrite ions, which can 
be estimated by Griess reagent [62]. The activity of ascorbic acid (36.12 mg/mL) is 
comparable with those of ligand (35.88 mg/mL) than that of other fractions. It has been 
reported that the antioxidant activity of compounds may result from the neutralization of free 
radicals initiating oxidation processes, or from the termination of radical chain reactions, due 
to their hydrogen donating ability [57]. 
3.8. Anti microbial activity 
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The in vitro biological activity has been evaluated qualitatively for its anti-microbial 
and anti-fungal activities (average of three determinations) using disc diffusion method 
against three gram positive bacteria Bacillus subtilis, Staphylococcus aureus, and 
Stapylococcus albush  and three gram negative bacteria Salmonella paratyphi, Escherichia 
coli and Klebsella pneumonia along with fungi C.albicans, A.fumigates and A.niger at 
concentration 100 µg/mL.  Ciprofloxacin (10 µg/mL) was used as positive control, while 
DMSO as the solvent to prepare the stock solution play no role in growth inhibition of the 
bacteria [63]. Antimicrobial activity of silver has been known for a long time and is 
attributable to the silver cation Ag+, which binds strongly to electron donor groups (sulfur, 
oxygen and nitrogen) present in biological molecules. Screening data of anti microbial 
activities are given in Table 2. From the zone of inhibition  diameter data, it’s clear that the 
metallic silver and complex  show great activity against both of the gram negative and gram 
positive bacteria, while there is little moderate inhibition zone observed for ligand. The 
activity of ligand might be due to the presence of azomethine group that play an important 
role. In particular, complex shows excellent activity against the Escherichia coli (G-) and 
Staphylococcus aureus (G+) bacterium comparatively lower than the drug reference. This 
difference in the activity of ligand and corresponding Ag(I) complex was explained by 
Tweedy’s chelation theory [64]. The activity might be due to the liphophilic nature of 
complex upon chelation of metal, which in turn resulted by the increase in electron 
delocalisation. However, they exhibited obviously enhanced activity against fungus C. 
albicans. Minimum inhibitory concentrations (MICs) were determined as a representative 
against Escherichia coli (G-) Staphylococcus aureus (G+) and C.albicans by the broth micro 
dilution method. Silver and its complex show remarkable activity against Escherichia coli 
with the MIC value of 40.2 and 31.3 µg/mL respectively.  However, moderate activity is 
found for Staphylococcus aureus and yeast (C.albicans). 
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3.9. Cytotoxicity assay 
 Since ligand and complex have the ability to bind DNA and BSA, in order to evaluate 
the antitumor activity of complex in comparison to free ligand, we examined the effect of 
synthesized ligand and silver complex on the cell response of the human breast cancer (MCF-
7) cell line by using the MTT assay and compared to reference Doxorubicin (DOX).  Silver 
in various forms (nanoparticles, coordination complexes and organometallic compounds) is 
now being focussed due to its significant effect against cancer cells [65]. Fig. S18 shows the 
In vitro cytotoxic activity of compounds (10-100 µM concentrations) against selected cancer 
cells. The IC50 values of compounds against 27±1.5 (H2L), 24±1.3 µM [Ag(HL)(H2L)] 
inhibitory concentration obtained for MCF-7 breast cancer cells. In the same condition, the 
IC50 of DOX was found to be 18±0.9 µM. Compared to ligand, silver complex has shown 
better cytotoxicity. This could be attributed to the presence of silver ion that synergistically 
increased the cytotoxicity. Most important criteria for an anti cancer drug is to show 
minimum or no side effects to the normal cells in addition to the tumour cells of the patients. 
In addition, the cytotoxic activities of the compounds were also evaluated against normal 
human breast cells HBL-100 (Fig. S18). From the result it was observed that both the ligand 
and complex were non toxic to normal cell. 
3.9.1. Cell morphoslogy & Fluorescence microscopy analysis 
Morphological changes induced in MCF-7 human breast cancer cells after treatment of 
compounds with their respective inhibitory concentration for 24 h are shown in Fig. 4. Phase-
contrast micrographs reveal that the compound induces increased cell shrinkage, membrane 
blebbing and forms floating cells, compared to the control in a dose-dependent manner (Fig. 
4 b-d).  
To elucidate the apoptotic activity of synthesized compounds, apoptotic staining 
fluorescence microscopic analysis was carried out. Acridine orange- Ethidium bromide (AO-
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EtBr) staining uses a combination of two dyes to visualise cells with aberrant chromatin 
organisation [66].  Fluorescence microscopy images of MCF-7 cancer cells in the absence 
(Control) and presence of compounds are shown in Fig. 5. The control viable cells have 
uniformly green fluorescing nuclei. After treatment of cells with compounds, we have 
observed morphological changes such as presence of late apoptotic cells that have orange to 
red nuclei with condensed or fragmented chromatin and necrotic cells. The results indicate 
that the silver complex induce cell death through apoptosis compared to that of ligand.   
In order to further confirm the nuclear condensation and fragmentation of compounds 
on selected cancer cells we evaluated the DAPI staining method. 4,6-diamidino-2-
phenylindole-2-HCl (DAPI) binds DNA providing a blue fluorescence when viewed under 
ultraviolet light. Fluorescence microscopy images of breast cancer cells after 24 h stained 
with DAPI in the presence and absence of compounds are shown in Fig. 6. It is found that 
compounds (Fig. 6 b-d) shown higher level of nuclear fragmentation and the untreated cells 
do not show any significant changes in the nuclear appearance. Complex treated MCF-7 
cancer cells shows bright fetches which indicate the condensed chromatins and nuclear 
fragmentations in the cancer cells and is comparable to the control and found to be 
significant. 
4. Conclusion  
In conclusion, new 2-(Methoxycarbonyl-hydrazono)-pentanedioic acid and its silver 
complex have been synthesised and characterised by elemental, spectral and thermal 
analyses. Single crystal XRD analysis strengthens the evidence of physicochemical 
characterisation. The groove binding mode of CT-DNA and static binding mode of BSA 
towards complex was identified by UV-Visible absorption and emission measurements. The 
complex was effective towards bacteria and fungi cells, in particular to Escherichia coli (G-) 
and Staphylococcus aureus (G+) bacterium. Cytotoxicity reveals that the complex acts as a 
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potential anticancer agent by inducing phenotypical changes, like increasing the membrane 
permeability, nuclear fragmentation and finally apoptotic cell death. It appears that the silver 
complex is more likely to become antibiotics [67] than anticancer drugs [68]. These findings 
give a clear indication that the complex has the potential to serve as a biomaterial in various 
aspects of chemotherapeutic agents. The synthesis of metal complexes using Schiff bases 
derived from methyl and ethyl carbazate analogues as ligands is in progress and will be 
reported in due course. 
Acknowledgement- 
S.P gratefully acknowledges the financial assistance received from the Women Scientist 
Scheme – WOS (A), Department of Science and Technology, New Delhi, India [Grant No. 
SR/WOS(A)/CS-42/2013]. S.G is thankful to University Grants Commission, New Delhi for 
the award of UGC-Emeritus Fellowship. 
Appendix A. Supplementary data 
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Scheme 1 Synthesis of Ligand (H2L) and complex [Ag(HL)(H2L)] 
Fig. 1. X-ray molecular structure of H2L.H2O (a) and [Ag(HL)(H2L)] (b) with atom 
labelling scheme (thermal ellipsoids are plotted at 50% probability). 
Fig. 2 Plot of F0/F vs. [Q] 
Fig. 3 Trends in inhibition of various radicals by ligand and complex along with the standard 
AA and BHA.  
Fig. 4 Microscopic images of MCF-7 cancer cells treated with compounds (ctrl (a), 10(b), 
20(c), 40µM (d)) 
Fig. 5 AO/EtBr staining of MCF-7 cells using fluorescence microscopy after treatment with 
ligand and complex (0(a), 10(b), 20(c), 40 µM(d)) for 24 h. 
Fig. 6 Fluorescence microscopic images of MCF-7 cells after treatment with ligand and 
complex (0(a), 10(b), 20(c), 40µM (d)) for 24 h. Cells were stained with DAPI 
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Fig. 1. X-ray molecular structure of H2L.H2O (a) and [Ag(HL)(H2L)] (b) with atom 
labelling scheme (thermal ellipsoids are plotted at 50% probability). 
 
 
 
 
 
 
 
 
 
Fig. 2 Plot of F0/F vs. [Q] 
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Fig. 3 Trends in inhibition of various radicals by ligand and complex along with the standard 
AA and BHA.  
 
 
Fig.4 Microscopic images of MCF-7 cancer cells treated with compounds (ctrl (a), 10(b), 
20(c), 40µM (d)) 
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Fig. 5 AO/EtBr staining of MCF-7 cells using fluorescence microscopy after treatment 
with ligand and complex (0(a), 10(b), 20(c), 40 µM(d)) for 24 h. 
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Fig. 6 Fluorescence microscopic images of MCF-7 cells after treatment with ligand and 
complex (0(a), 10(b), 20(c), 40µM (d)) for 24 h. Cells were stained with DAPI 
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Table 1 Crystal structure details of H2L.H2O and [Ag(H2L)(HL)] 
Table 2 Antibacterial and antifungal activity of 100 µg/mL concentration of ligand, 
complex and metallic silver along with standard 
 
 
 
 
Table 1 
Crystal structure details of H2L.H2O and [Ag(H2L)(HL)] 
 
Compound  H2L.H2O [Ag(HL)(H2L)] 
Emprical Formula  C7H12N2O7  C14H19AgN4O12 
Dcalc./ g cm-3 1.533 1.886 
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Formula Weight  236.19  543.20 
T/K  120(2)  120(2)  
Crystal System  monoclinic  monoclinic  
Space Group  P21/c  P21/c  
a/Å  15.4170(3)  11.3309(4)  
b/Å  5.69453(9)  12.1728(4)  
c/Å  12.1388(3)  13.8242(5)  
α/°  90  90  
β/°  106.146(2)  92.035(3)  
γ/°  90  90  
V/Å3  1023.66(4)  1905.56(11)  
Z  4  4  
µ/mm-1  0.139  1.134  
Rint  0.0402  0.0799 
Crystal size/mm3 0.79×0.35×0.14 0.41×0.14×0.13 
Measured Refl.  51136  22881 
Independent Refl.  3691  3940  
Reflections Used  3214  3371  
Restraints  0  36 
GooF  1.040  1.083 
Θmax, Θmin/˚ 32.844, 3.381 26.498, 2.457 
Npar 151 288 
Final R indexes 
[I>=2σ (I)]  
R1 = 0.0357, wR2 = 0.0913 R1 = 0.0423, wR2 = 
0.1054 
Final R indexes [all 
data] 
R1 = 0.0436, wR2 = 0.0967 R1 = 0.0500, wR2 = 
0.1110 
Largest diff. peak/hole 
/ e Å-3 
0.460/-0.252 2.123/-1.185 
 
 
 
 
 
Table 2 
Antibacterial and antifungal activity of 100 µg/mL concentration of ligand, complex and 
metallic silver along with standard 
Diameter of zone of inhibition in mm at 100 µg/ml and DMSO as control 
Organism H2L.H2O [Ag(HL)(H2L)] Ag Std 
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Bacteria      
Bacillus substilis 12.2 14.9 10.2 34.25 
Staphylococcus aureus 12.4 16.9 15.9 14.8 
Stapylococcus albush 11.9 16.7 15.2 28.5 
Salmonella paratyphi 10.7 18.5 15.6 28 
Escherichia coli 12.1 17.9 16.8 22.9 
Klebsella pneumonia 09.5 18.6 12.8 30.0 
Fungi      
C.albicans 07.4 15.6 17.8 37.2 
A.fumigates 07.2 07.3 16.9 41.5 
A.niger 11.2 10.5 9.2 35.1 
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Graphical Abstract  
 
 
 
Antimicrobial and cytotoxic activities of silver are due to its ionised Ag+ form, and its 
ability to cause damage to cells by interacting with cell membrane protein and DNA. These 
effects have been visualised in our newly synthesised ligand and complex through BSA and 
CT-DNA binding studies. Silver sheets are produced by the decomposition of silver complex. 
Antibacterial and antifungal activities have been studied. With the increasing number of 
antibiotic strains of bacteria and fungi and low toxicity of silver, the use of silver as an 
antimicrobial agent is an exciting with a great deal in many fields. 
 
 
  
  
34 
 
Highlights  
 New Silver(I) hydrazone Schiff base complex synthesised and characterised. 
 Ligand and silver complex has the ability to interact with biomolecules (DNA,BSA). 
 Excellent antimicrobial activity was observed for complex than free ligand. 
 Preferential cytotoxicity observed for complex towards MCF-7 cancer cells and 
insignificant to normal breast cells. 
 
